Marinus Pharma (NASDAQ: MRNS) reported Q1 EPS of ($0.68), $0.03 worse than the analyst estimate of ($0.65). Revenue for the quarter came in at $7.68 million versus the consensus estimate of $9.04 million.

For earnings history and earnings-related data on Marinus Pharma (MRNS) click here.